118 related articles for article (PubMed ID: 30635393)
1. A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8
Çuburu N; Kim R; Guittard GC; Thompson CD; Day PM; Hamm DE; Pang YS; Graham BS; Lowy DR; Schiller JT
J Immunol; 2019 Feb; 202(4):1250-1264. PubMed ID: 30635393
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4
Quadiri A; Prakash S; Dhanushkodi NR; Singer M; Zayou L; Shaik AM; Sun M; Suzer B; Lau LSL; Chilukurri A; Vahed H; Schaefer H; BenMohamed L
J Virol; 2024 May; 98(5):e0159623. PubMed ID: 38587378
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.
Soong RS; Song L; Trieu J; Knoff J; He L; Tsai YC; Huh W; Chang YN; Cheng WF; Roden RB; Wu TC; Trimble CL; Hung CF
Clin Cancer Res; 2014 Nov; 20(21):5456-67. PubMed ID: 24893628
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Prime/Pull Vaccination of HSV-2 Infected Guinea Pigs with the Ribonucleotide Reductase 2 (RR2) Protein and CXCL11 Chemokine Boosts Antiviral Local Tissue-Resident and Effector Memory CD4
Quadiri A; Prakash S; Dhanushkodi NR; Singer M; Zayou L; Shaik AM; Sun M; Suzer B; Lau L; Chilukurri A; Vahed H; Schaefer H; BenMohamed L
bioRxiv; 2023 Aug; ():. PubMed ID: 37609157
[TBL] [Abstract][Full Text] [Related]
5. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells.
Künzli M; O'Flanagan SD; LaRue M; Talukder P; Dileepan T; Stolley JM; Soerens AG; Quarnstrom CF; Wijeyesinghe S; Ye Y; McPartlan JS; Mitchell JS; Mandl CW; Vile R; Jenkins MK; Ahmed R; Vezys V; Chahal JS; Masopust D
Sci Immunol; 2022 Dec; 7(78):eadd3075. PubMed ID: 36459542
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral vaccines promote protective tissue-resident memory T cell populations against cancer.
van der Gracht ET; Schoonderwoerd MJ; van Duikeren S; Yilmaz AN; Behr FM; Colston JM; Lee LN; Yagita H; van Gisbergen KP; Hawinkels LJ; Koning F; Klenerman P; Arens R
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33293355
[TBL] [Abstract][Full Text] [Related]
7. Viral MHCI inhibition evades tissue-resident memory T cell formation and responses.
Lauron EJ; Yang L; Harvey IB; Sojka DK; Williams GD; Paley MA; Bern MD; Park E; Victorino F; Boon ACM; Yokoyama WM
J Exp Med; 2019 Jan; 216(1):117-132. PubMed ID: 30559127
[TBL] [Abstract][Full Text] [Related]
8. CXCR3 Provides a Competitive Advantage for Retention of
Armitage E; Quan D; Flórido M; Palendira U; Triccas JA; Britton WJ
Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896952
[No Abstract] [Full Text] [Related]
9. FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
Zhao Q; Hu J; Kong L; Jiang S; Tian X; Wang J; Hashizume R; Jia Z; Fowlkes NW; Yan J; Xia X; Yi SF; Dao LH; Masopust D; Heimberger AB; Li S
Nat Commun; 2023 Feb; 14(1):735. PubMed ID: 36759517
[TBL] [Abstract][Full Text] [Related]
10. Early precursors and molecular determinants of tissue-resident memory CD8
Kurd NS; He Z; Louis TL; Milner JJ; Omilusik KD; Jin W; Tsai MS; Widjaja CE; Kanbar JN; Olvera JG; Tysl T; Quezada LK; Boland BS; Huang WJ; Murre C; Goldrath AW; Yeo GW; Chang JT
Sci Immunol; 2020 May; 5(47):. PubMed ID: 32414833
[TBL] [Abstract][Full Text] [Related]
11. Vaccine induced memory CD8
Zhou J; Uddback I; Kohlmeier JE; Christensen JP; Thomsen AR
Front Immunol; 2023; 14():1322536. PubMed ID: 38164135
[TBL] [Abstract][Full Text] [Related]
12. Optimal generation of hepatic tissue-resident memory CD4 T cells requires IL-1 and IL-2.
Depew CE; Rixon JA; McSorley SJ
Proc Natl Acad Sci U S A; 2023 Apr; 120(16):e2214699120. PubMed ID: 37040404
[TBL] [Abstract][Full Text] [Related]
13. Epithelial organoid supports resident memory CD8 T cell differentiation.
Ulibarri MR; Lin Y; Ramprashad JR; Han G; Hasan MH; Mithila FJ; Ma C; Gopinath S; Zhang N; Milner JJ; Beura LK
bioRxiv; 2023 Dec; ():. PubMed ID: 38076957
[TBL] [Abstract][Full Text] [Related]
14. Exocrine gland-resident memory CD8
Ruef N; Martínez Magdaleno J; Ficht X; Purvanov V; Palayret M; Wissmann S; Pfenninger P; Stolp B; Thelen F; Barreto de Albuquerque J; Germann P; Sharpe J; Abe J; Legler DF; Stein JV
Sci Immunol; 2023 Dec; 8(90):eadd5724. PubMed ID: 38134242
[TBL] [Abstract][Full Text] [Related]
15. Tissue-resident lymphocytes: from adaptive to innate immunity.
Sun H; Sun C; Xiao W; Sun R
Cell Mol Immunol; 2019 Mar; 16(3):205-215. PubMed ID: 30635650
[TBL] [Abstract][Full Text] [Related]
16. Zymosan by-passes the requirement for pulmonary antigen encounter in lung tissue-resident memory CD8
Caminschi I; Lahoud MH; Pizzolla A; Wakim LM
Mucosal Immunol; 2019 Mar; 12(2):403-412. PubMed ID: 30664708
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer prevention by vaccination: review.
González-Rodríguez JC; Cruz-Valdez A; Madrid-Marina V
Front Oncol; 2024; 14():1386167. PubMed ID: 38715779
[TBL] [Abstract][Full Text] [Related]
18. Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches.
Mittra S; Harding SM; Kaech SM
J Immunol; 2023 Sep; 211(6):907-916. PubMed ID: 37669503
[TBL] [Abstract][Full Text] [Related]
19. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines.
Kim H; Choi HG; Shin SJ
Front Immunol; 2023; 14():1193058. PubMed ID: 37638056
[TBL] [Abstract][Full Text] [Related]
20. Establishment of isotype-switched, antigen-specific B cells in multiple mucosal tissues using non-mucosal immunization.
Prior JT; Limbert VM; Horowitz RM; D'Souza SJ; Bachnak L; Godwin MS; Bauer DL; Harrell JE; Morici LA; Taylor JJ; McLachlan JB
NPJ Vaccines; 2023 May; 8(1):80. PubMed ID: 37258506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
